Targeting the protective shield of cancers
top of page
Search
Cancer cells have different mechanisms to help them escape destruction by the immune system. Solid tumours, for example, are often...
- Apr 6, 2023
- 2 min
BioMed X and Merck Expand Collaboration
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies After successfully...
- Apr 6, 2023
- 3 min
Epigenetic fingerprint as proof of origin for chicken, shrimp and salmon
Free-range organic chicken or factory farming? Scientists at the German Cancer Research Center (DKFZ) have developed a new detection...
- Apr 5, 2023
- 1 min
New Member: Welcome in our cluster to CORAT Therapeutics
CORAT Therapeutics GmbH develops innovative antibody-based drugs for treatment of diseases with high medical need. CORAT antibodies are...
- Mar 31, 2023
- 3 min
German Biotechnology Days in Wiesbaden - the magic is back
(Berlin - 30 March 2023) Around 750 participants gathered at the German Biotechnology Days (DBT) in Wiesbaden on 28 and 29 March for...
- Mar 31, 2023
- 1 min
Innovation Award of the BioRegions
Innovation Award of the BioRegions: Outstanding projects from the fields of biotechnology and genetics awarded The award ceremony for the...
- Mar 31, 2023
- 1 min
Apogenix’ partner CANbridge announces 67 % five-year overall survival rate compared to 8.2 %
Apogenix’ Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept...
- Mar 31, 2023
- 3 min
AION Labs, In Continued Partnership with BioMed X, Launches First 2023 Global Call for Applications
AION Labs, In Continued Partnership with BioMed X, Launches First 2023 Global Call for Applications: Developing Molecular Glues...
- Mar 31, 2023
- 3 min
Neuroblastoma: decision on malignancy already made during pregnancy
Neuroblastomas, common tumors in infants and young children, develop during the first trimester of pregnancy, regardless of their later ...
- Mar 31, 2023
- 3 min
Affimed Announces First Patient Successfully Dosed in the First-in-Human Study of AFM28
Affimed Announces First Patient Successfully Dosed in the First-in-Human Study of AFM28 for the Treatment of Patients with Relapsed / ...
- Mar 31, 2023
- 6 min
NOV03 Consistently Met Primary Endpoints for Signs and Symptoms of Dry Eye Disease
NOV03 Consistently Met Primary Endpoints for Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction Bausch +...
- Mar 31, 2023
- 4 min
Shining light on the mechanics of embryo development
A remarkable new microscope built by EMBL researchers allows scientists to observe the dynamics of mechanical properties inside...
bottom of page